DNA methylation markers predict recurrence-free interval in triple-negative breast cancer

We lack tools to risk-stratify triple-negative breast cancer (TNBC). Our goal was to develop molecular tools to predict disease recurrence. Methylation array analysis was performed on 110 samples treated by locoregional therapy obtained from institutional cohorts. Discovered marker sets were then te...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Breast Cancer
Autors principals: Fackler, Mary Jo, Cho, Soonweng, Cope, Leslie, Gabrielson, Edward, Visvanathan, Kala, Wilsbach, Kathleen, Meir-Levi, Danielle, Lynch, Charles F., Marks, Jeffrey, Geradts, Joseph, Regan, Meredith M., Viale, Giuseppe, Wolff, Antonio C., Sukumar, Saraswati, Umbricht, Christopher B.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994477/
https://ncbi.nlm.nih.gov/pubmed/32025567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-020-0145-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars